Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses

被引：0
|
作者：
Palmer, Christine D. [1 ]
Rappaport, Amy R. [2 ]
Hart, Meghan G. [1 ]
Kraemer, Lauren D. [1 ]
Kounlavouth, Sonia [1 ]
Marrali, Martina [1 ]
Jaroslaysky, Jason R. [1 ]
Nganje, Charmaine N. [1 ]
Shen, Annie [2 ]
Boucher, Gregory R. [2 ]
Kachura, Melissa A. [2 ]
Scallan, Ciaran D. [2 ]
Hong, Sue-Jean [2 ]
Gitlin, Leonid [2 ]
Spira, Alexander I. [3 ]
Kyi, Chrisann [4 ]
Catenacci, Daniel V. [5 ]
Rousseau, Raphael [2 ]
Ferguson, Andrew [1 ]
Jooss, Karin [2 ]
机构：
[1] Gritstone Bio, Cambridge, MA USA
[2] Gritstone Bio, Emeryville, CA USA
[3] Virginia Canc Specialists, Fairfax, VA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Univ Chicago, Chicago, IL USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4159
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Novel approach for the detection of antigen-specific CD8 T cell responses corresponding to treatment outcome in HPV plus cancer patients
    Sierra, Gloria
    Ouerkaxi, Wushouer
    Daftarian, Pirouz
    Sastry, Jagannadha K.
    George, Marybeth
    Delcommenne, Marc
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [22] Late-differentiated effector neoantigen-specific CD8+T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment
    Fehlings, M.
    Nardin, A.
    Jhunjhunwala, S.
    Kowanetz, M.
    O'Gorman, B.
    Hegde, P.
    Li, J.
    Sumatoh, H.
    Lee, B.
    Kim, L.
    Flynn, S.
    Ballinger, M.
    Newell, E.
    Yadav, M.
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : S2 - S3
  • [23] JCAR017 Is a Defined Composition CAR T Cell Product with Product and Process Controls That Deliver Precise Doses of CD4 and CD8 CAR T Cell to Patients with NHL
    Ramsborg, Christopher G.
    Guptill, Paul
    Weber, Clinton
    Christin, Brian
    Larson, Ryan P.
    Lewis, Kenneth
    Mallaney, Mary
    Bowen, Michael
    Higham, Eileen
    Albertson, Tina
    BLOOD, 2017, 130
  • [24] Harnessing self-assembling peptide nanofibers to prime robust tumor-specific CD8 T cell responses in mice
    Mohseninia, Atefeh
    Dehghani, Parva
    Bargahi, Afshar
    Rad-Malekshahi, Mazda
    Rahimikian, Raha
    Movahed, Ali
    Farzaneh, Mohammad Reza
    Mohammadi, Mohsen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 104
  • [25] Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses
    Trautmann, L
    Rimbert, M
    Echasserieau, K
    Saulquin, X
    Neveu, B
    Dechanet, J
    Cerundolo, V
    Bonneville, M
    JOURNAL OF IMMUNOLOGY, 2005, 175 (09): : 6123 - 6132
  • [26] Peripheral self-reactivity regulates antigen-specific CD8 T-cell responses and cell division under physiological conditions
    Swee, Lee Kim
    Tan, Zhen Wei
    Sanecka, Anna
    Yoshida, Nagisa
    Patel, Harshil
    Grotenbreg, Gijsbert
    Frickel, Eva-Maria
    Ploegh, Hidde L.
    OPEN BIOLOGY, 2016, 6 (11):
  • [27] A novel heterologous prime boost vaccine system drives tumor specific and potent CD8 T cell responses for cancer immunotherapy
    Blair, Wade
    Grotenbreg, Gijsbert
    Scallan, Ciaran
    Rappaport, Amy
    Greer, Renee
    Gitlin, Leonid
    Lam, Kieu
    Heyes, James
    Van Abbema, Anne
    Hanson, Hadley
    Schreiner, Petra
    Jooss, Karin
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Telomerase-transfected Lymphocytes Stimulate Antigen-specific CD8 T Cell Responses in Patients With Stage III Melanoma
    Rosette, Caridad
    Laysa, Fernando B.
    Mascarenas, Mary K.
    Patkar, Seema
    Berglin, Jon
    Gerloni, Mara
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 948 - 948
  • [29] Late-differentiated effector neoantigen-specific CD8+T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
    Fehlings, Michael
    Jhunjhunwala, Suchit
    Kowanetz, Marcin
    O'Gorman, William E.
    Hegde, Priti S.
    Sumatoh, Hermi
    Lee, Boon Heng
    Nardin, Alessandra
    Becht, Etienne
    Flynn, Susan
    Ballinger, Marcus
    Newell, Evan W.
    Yadav, Mahesh
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [30] Persistence of EBV Antigen-Specific CD8 T Cell Clonotypes during Homeostatic Immune Reconstitution in Cancer Patients
    Iancu, Emanuela M.
    Gannon, Philippe O.
    Laurent, Julien
    Gupta, Bhawna
    Romero, Pedro
    Michielin, Olivier
    Romano, Emanuela
    Speiser, Daniel E.
    Rufer, Nathalie
    PLOS ONE, 2013, 8 (10):
12345